Status:
COMPLETED
Physician Liver Function Test (LFT) Monitoring for Tykerb Pts
Lead Sponsor:
GlaxoSmithKline
Conditions:
Cancer
Eligibility:
FEMALE
19+ years
Brief Summary
In July 2008, the lapatinib (Tykerb) Prescribing Information (label) was updated to include a boxed warning related to hepatotoxcity and detailed instructions for monitoring liver function before and ...
Eligibility Criteria
Inclusion
- Female aged \>= 19 years
- A diagnosis of breast cancer with documented metastatic disease (as defined by stage at diagnosis, evidence of disease progression, and/or line of therapy);
- Documented order/prescription for lapatanib from January 1, 2007 - December 31, 2009;
- Received care at a practice utilizing the full electronic medical record capabilities of US Oncology's iKnowMed system
Exclusion
- Patients participating in clinical trials
- Patients receiving care for another cancer during the study time period
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01462552
Start Date
December 1 2010
End Date
August 1 2011
Last Update
April 15 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.